Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome

被引:23
|
作者
Selman, Helmy [1 ,2 ]
Brusco, Gian Francesco [1 ]
Fiorini, Fabrizio [2 ]
Barnocchi, Nicoletta [1 ,2 ]
Mariani, Monica [1 ]
El-Danasouri, Imam [3 ]
机构
[1] Policlin Perugia, Ctr Sterilita & Fecondaz Assistita, I-06121 Perugia, Italy
[2] Primigenia Ctr, Perugia, Italy
[3] IEMA, Chieti, Italy
关键词
Cryopreservation; embryo; ovarian hyperstimulation; vitrification; warming; ELECTIVE CRYOPRESERVATION; PREGNANCIES; WOMEN; SUBSEQUENT; PREVENT; BIRTH;
D O I
10.1016/j.fertnstert.2008.12.027
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study aimed to evaluate the efficacy of embryo vitrification as an emergency procedure for patients at high risk of developing ovarian hyperstimulation syndrome (OHSS). A total of 69 embryos, derived from 24 patients for whom embryo transfer could not be performed because of the risk of developing OHSS, were vitrified and warmed for deferred embryo transfer. Surviving embryos were transferred, resulting in 10 clinical pregnancies, of which 4 were successfully delivered and the remaining 6 are still ongoing. (Fertil Steril (R) 2009;91:1611-3. (C) 2009 by American Society for Reproductive Medicine.)
引用
收藏
页码:1611 / 1613
页数:3
相关论文
共 50 条
  • [31] VON-WILLEBRAND-FACTOR - AN ENDOTHELIAL MARKER TO MONITOR IN-VITRO FERTILIZATION PATIENTS WITH OVARIAN HYPERSTIMULATION SYNDROME
    TODOROW, S
    SCHRICKER, ST
    SIEBZEHNRUEBL, ER
    NEIDHARDT, B
    WILDT, L
    LANG, N
    HUMAN REPRODUCTION, 1993, 8 (12) : 2039 - 2046
  • [32] Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program
    Grochowski, D
    Wolczynski, S
    Kuczynski, W
    Domitrz, J
    Szamatowicz, J
    Szamatowicz, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (03) : 234 - 238
  • [33] Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program
    Artini, PG
    Fasciani, A
    Monti, M
    Luisi, S
    D'Ambrogio, G
    Genazzani, AR
    FERTILITY AND STERILITY, 1998, 70 (03) : 560 - 564
  • [34] Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial
    Palomba, Stefano
    Falbo, Angela
    Carrillo, Laura
    Villani, Maria Teresa
    Orio, Francesco
    Russo, Tiziana
    Di Cello, Annalisa
    Cappiello, Fulvio
    Capasso, Sabina
    Tolino, Achille
    Colao, Annamaria
    Mastrantonio, Pasquale
    La Sala, Giovanni Battista
    Zullo, Fulvio
    Cittadini, Ettore
    FERTILITY AND STERILITY, 2011, 96 (06) : 1384 - U369
  • [35] THE USE OF INTRAVENOUS ALBUMIN IN PATIENTS AT HIGH-RISK FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    ASCH, RH
    IVERY, G
    GOLDSMAN, M
    FREDERICK, JL
    STONE, SC
    BALMACEDA, JP
    HUMAN REPRODUCTION, 1993, 8 (07) : 1015 - 1020
  • [36] Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization
    Shapiro, BS
    Daneshmand, ST
    Garner, FC
    Aguirre, M
    Ross, R
    Morris, S
    FERTILITY AND STERILITY, 2005, 84 (01) : 93 - 98
  • [37] OUTCOME OF THAW EMBRYO-TRANSFER AFTER CRYOPRESERVATION OF ALL EMBRYOS IN PATIENTS AT RISK OF OVARIAN HYPERSTIMULATION SYNDROME
    PATTINSON, HA
    HIGNETT, M
    DUNPHY, BC
    FLEETHAM, JA
    FERTILITY AND STERILITY, 1994, 62 (06) : 1192 - 1196
  • [38] Outcome of frozen embryo replacement cycles following elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome
    Awonuga, AO
    Dean, N
    Zaidi, J
    Pittrof, RU
    Bekir, JS
    Tan, SL
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (04) : 293 - 297
  • [39] Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment
    Ayustawati
    Shibahara, H
    Hirano, Y
    Suzuki, T
    Takamizawa, S
    Suzuki, M
    FERTILITY AND STERILITY, 2004, 82 (03) : 579 - 585
  • [40] Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
    Abbara, Ali
    Jayasena, Channa N.
    Christopoulos, Georgios
    Narayanaswamy, Shakunthala
    Izzi-Engbeaya, Chioma
    Nijher, Gurjinder M. K.
    Comninos, Alexander N.
    Peters, Deborah
    Buckley, Adam
    Ratnasabapathy, Risheka
    Prague, Julia K.
    Salim, Rehan
    Lavery, Stuart A.
    Bloom, Stephen R.
    Szigeti, Matyas
    Ashby, Deborah A.
    Trew, Geoffrey H.
    Dhillo, Waljit S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (09): : 3322 - 3331